- Reuters•22 hours ago
The U.S. Food and Drug Administration said Pfizer Inc's process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas, was "out of control" and put patients at risk, according to a warning letter made public on Tuesday. In the Feb. 14 letter, the FDA said several products were contaminated with multiple foreign particulates and that the injectable antibiotic vancomycin had been compromised by cardboard pieces. The FDA warned the company it had failed to take corrective action.
- GlobeNewswire•yesterdayMomenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 28, 2017-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the ...
- Business Wire•5 days agoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
Goldberg Law PC announces that it is investigating Momenta Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||15.30 x 800|
|Ask||15.40 x 1000|
|Day's Range||15.30 - 16.09|
|52 Week Range||7.86 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-11.47|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|